Endymed Stock Beta
| ENDY Stock | 302.00 11.90 4.10% |
Endymed fundamentals help investors to digest information that contributes to Endymed's financial success or failures. It also enables traders to predict the movement of Endymed Stock. The fundamental analysis module provides a way to measure Endymed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Endymed stock.
Endymed |
Endymed Company Beta Analysis
Endymed's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Endymed Beta | -0.0864 |
Most of Endymed's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Endymed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Endymed has a Beta of -0.0864. This is 110.05% lower than that of the Health Care Equipment & Supplies sector and 108.31% lower than that of the Health Care industry. The beta for all Israel stocks is 42.4% lower than that of the firm.
Endymed Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Endymed's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Endymed could also be used in its relative valuation, which is a method of valuing Endymed by comparing valuation metrics of similar companies.Endymed is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning Endymed are expected to decrease at a much lower rate. During the bear market, Endymed is likely to outperform the market.
Endymed Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0385 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.85 M | |||
| Shares Outstanding | 13.76 M | |||
| Shares Owned By Insiders | 58.11 % | |||
| Price To Book | 0.70 X | |||
| Price To Sales | 1.52 X | |||
| Revenue | 21.78 M | |||
| Gross Profit | 10.06 M | |||
| EBITDA | 3.2 M | |||
| Net Income | 5.16 M | |||
| Cash And Equivalents | 5.02 M | |||
| Cash Per Share | 0.39 X | |||
| Total Debt | 463 K | |||
| Debt To Equity | 7.10 % | |||
| Current Ratio | 2.58 X | |||
| Book Value Per Share | 1.04 X | |||
| Cash Flow From Operations | 4.63 M | |||
| Earnings Per Share | 0.74 X | |||
| Number Of Employees | 41 | |||
| Beta | -0.0864 | |||
| Market Capitalization | 35.42 M | |||
| Total Asset | 19.6 M | |||
| Retained Earnings | (12 M) | |||
| Working Capital | 5 M | |||
| Current Asset | 9 M | |||
| Current Liabilities | 4 M | |||
| Z Score | 46.6 | |||
| Net Asset | 19.6 M |
About Endymed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Endymed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Endymed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Endymed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Endymed Stock
Endymed financial ratios help investors to determine whether Endymed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endymed with respect to the benefits of owning Endymed security.